Dual-specificity phosphatase 4 regulates STAT5 protein stability and helper T cell polarization

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Hsiao, Wan Yi ^a   Lin, Yu Chun ^a   Liao, Fang Hsuean ^a   Chan, Yi Chiao ^a   Huang, Ching Yu ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 4; STAT5 PROTEIN; UNCLASSIFIED DRUG; HYBRID PROTEIN; MKP2 PROTEIN, MOUSE; PROTEIN TYROSINE PHOSPHATASE; STAT5A PROTEIN, MOUSE;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME SUBSTRATE; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; TH17 CELL; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DEFICIENCY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN STABILITY; PROTEIN TYROSINE PHOSPHATASES; RECOMBINANT FUSION PROTEINS; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84957564551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145880     Document Type: Article

References (60)

1. Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008; 27: 253-261. doi: 10.1007/s10555-008-9123-1 PMID: 18330678
2. Huang CY, Tan TH. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012; 2: 24. doi: 10.1186/2045-3701-2-24 PMID: 22769588
3. Jeong DG, Wei CH, Ku B, Jeon TJ, Chien PN, Kim JK, et al. The family-wide structure and function of human dual-specificity protein phosphatases. Acta Crystallogr D Biol Crystallogr. 2014; 70: 421-435. doi: 10.1107/S1399004713029866 PMID: 24531476
4. Guan KL, Butch E. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J Biol Chem. 1995; 270: 7197-7203. PMID: 7535768
5. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem. 1996; 271: 6497-6501. PMID: 8626452
6. Sloss CM, Cadalbert L, Finn SG, Fuller SJ, Plevin R. Disruption of two putative nuclear localization sequences is required for cytosolic localization of mitogen-activated protein kinase phosphatase-2. Cell Signal. 2005; 17: 709-716. PMID: 15722195
7. Wang H, Lu Y, Huang W, Papoutsakis ET, Fuhrken P, Eklund EA. HoxA10 activates transcription of the gene encoding mitogen-activated protein kinase phosphatase 2 (Mkp2) in myeloid cells. J Biol Chem. 2007; 282: 16164-16176. PMID: 17430893
8. Shen WH, Wang J, Wu J, Zhurkin VB, Yin Y. Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis. Cancer Res. 2006; 66: 6033-6039. PMID: 16778175
9. Torres C, Francis MK, Lorenzini A, Tresini M, Cristofalo VJ. Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts. Exp Cell Res. 2003; 290: 195-206. PMID: 14567979
10. Meier A, Fiegler H, Munoz P, Ellis P, Rigler D, Langford C, et al. Spreading of mammalian DNA-damage response factors studied by ChIP-chip at damaged telomeres. Embo J. 2007; 26: 2707-2718. PMID: 17491589
11. Teng CH, Huang WN, Meng TC. Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J Biol Chem. 2007; 282: 28395-28407. PMID: 17681939
12. Ramesh S, Qi XJ, Wildey GM, Robinson J, Molkentin J, Letterio J, et al. TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep. 2008; 9: 990-997. doi: 10.1038/embor.2008.158 PMID: 18704116
13. Cornell TT, Rodenhouse P, Cai Q, Sun L, Shanley TP. Mitogen-activated protein kinase phosphatase 2 regulates the inflammatory response in sepsis. Infect Immun. 2010; 78: 2868-2876. doi: 10.1128/IAI. 00018-10 PMID: 20351138
14. Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, Kurnik M, et al. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 2010; 6: e1001192. doi: 10.1371/journal.ppat.1001192 PMID: 21085614
15. Huang CY, Lin YC, Hsiao WY, Liao FH, Huang PY, Tan TH. DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development. Eur J Immunol. 2012; 42: 476-488. doi: 10.1002/eji.201041295 PMID: 22101742
16. Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A. 2012; 109: E879-888. doi: 10.1073/pnas.1109797109 PMID: 22434910
17. Reiner SL. Development in motion: helper T cells at work. Cell. 2007; 129: 33-36. PMID: 17418783
18. Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 2010; 33: 153-165. doi: 10.1016/j.immuni.2010.08.004 PMID: 20732639
19. de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol. 2004; 34: 2480-2488. PMID: 15307180
20. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007; 26: 371-381. PMID: 17363300
21. Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One. 2010; 5: e15531. doi: 10.1371/journal.pone.0015531 PMID: 21209700
22. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC, et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol. 2008; 181: 3750-3754. PMID: 18768826
23. Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002; 169: 4712-4716. PMID: 12391178
24. Kim HP, Imbert J, Leonard WJ. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006; 17: 349-366. PMID: 16911870
25. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell. 1998; 93: 827-839. PMID: 9630226
26. Reich NC. STATs get their move on. JAKSTAT. 2013; 2: e27080. doi: 10.4161/jkst.27080 PMID: 24470978
27. Shuai K. The STAT family of proteins in cytokine signaling. Prog Biophys Mol Biol. 1999; 71: 405-422. PMID: 10354707
28. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007; 282: 20059-20063. PMID: 17502367
29. Wei L, Laurence A, O'Shea JJ. New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin Cell Dev Biol. 2008; 19: 394-400. doi: 10.1016/j.semcdb.2008.07.011 PMID: 18708155
30. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2007; 178: 280-290. PMID: 17182565
31. Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. J Immunol. 2011; 186: 6329-6337. doi: 10.4049/jimmunol.1100061 PMID: 21525380
32. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 1994; 13: 4361-4369. PMID: 7925280
33. Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, et al. Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression. Mol Cell Endocrinol. 2001; 183: 151-163. PMID: 11604235
34. Beadling C, Ng J, Babbage JW, Cantrell DA. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 1996; 15: 1902-1913. PMID: 8617237
35. Yu CL, Jin YJ, Burakoff SJ. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem. 2000; 275: 599-604. PMID: 10617656
36. Xiao W, Hong H, Kawakami Y, Kato Y, Wu D, Yasudo H, et al. Tumor suppression by phospholipase Cbeta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell. 2009; 16: 161-171. doi: 10.1016/j. ccr.2009.05.018 PMID: 19647226
37. Hoyt R, Zhu W, Cerignoli F, Alonso A, Mustelin T, David M. Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase. J Immunol. 2007; 179: 3402-3406. PMID: 17785772
38. Aoki N, Matsuda T. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J Biol Chem. 2000; 275: 39718-39726. PMID: 10993888
39. Iyer J, Reich NC. Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain. FASEB J. 2008; 22: 391-400. PMID: 17846080
40. Shin HY, Reich NC. Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal. J Cell Sci. 2013; 126: 3333-3343. doi: 10.1242/jcs.123042 PMID: 23704351
41. Wang D, Moriggl R, Stravopodis D, Carpino N, Marine JC, Teglund S, et al. A small amphipathic alphahelical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5. EMBO J. 2000; 19: 392-399. PMID: 10654938
42. Floyd ZE, Segura BM, He F, Stephens JM. Degradation of STAT5 proteins in 3T3-L1 adipocytes is induced by TNF-{alpha} and cycloheximide in a manner independent of STAT5A activation. Am J Physiol Endocrinol Metab. 2007; 292: E461-468. PMID: 16985255
43. Fievez L, Desmet C, Henry E, Pajak B, Hegenbarth S, Garze V, et al. STAT5 is an ambivalent regulator of neutrophil homeostasis. PLoS One. 2007; 2: e727. PMID: 17710127
44. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005; 22: 329-341. PMID: 15780990
45. Ai HW, Hazelwood KL, Davidson MW, Campbell RE. Fluorescent protein FRET pairs for ratiometric imaging of dual biosensors. Nat Methods. 2008; 5: 401-403. doi: 10.1038/nmeth.1207 PMID: 18425137
46. von Laue S, Finidori J, Maamra M, Shen XY, Justice S, Dobson PR, et al. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone. J Endocrinol. 2000; 165: 301-311. PMID: 10810294
47. Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D, Decker T. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol. 1996; 16: 6937-6944. PMID: 8943349
48. Ferraro A, D'Alise AM, Raj T, Asinovski N, Phillips R, Ergun A, et al. Interindividual variation in human T regulatory cells. Proc Natl Acad Sci U S A. 2014; 111: E1111-1120. doi: 10.1073/pnas.1401343111 PMID: 24610777
49. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30: 531-564. doi: 10.1146/annurev.immunol.25.022106.141623 PMID: 22224781
50. Chang CF, D'Souza WN, Ch'en IL, Pages G, Pouyssegur J, Hedrick SM. Polar opposites: Erk direction of CD4 T cell subsets. J Immunol. 2012; 189: 721-731. doi: 10.4049/jimmunol.1103015 PMID: 22675204
51. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 2007; 109: 4368-4375. PMID: 17227828
52. King AG, Ozanne BW, Smythe C, Ashworth A. Isolation and characterisation of a uniquely regulated threonine, tyrosine phosphatase (TYP 1) which inactivates ERK2 and p54jnk. Oncogene. 1995; 11: 2553-2563. PMID: 8545112
53. Oda A, Wakao H, Fujita H. Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease. Blood. 2002; 99: 1850-1852. PMID: 11861304
54. Neculai D, Neculai AM, Verrier S, Straub K, Klumpp K, Pfitzner E, et al. Structure of the unphosphorylated STAT5a dimer. J Biol Chem. 2005; 280: 40782-40787. PMID: 16192273
55. Auger-Messier M, Accornero F, Goonasekera SA, Bueno OF, Lorenz JN, van Berlo JH, et al. Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy. Circ Res. 2013; 112: 48-56. doi: 10.1161/CIRCRESAHA.112.272963 PMID: 22993413
56. Kovanen PE, Bernard J, Al-Shami A, Liu C, Bollenbacher-Reilley J, Young L, et al. T-cell development and function are modulated by dual specificity phosphatase DUSP5. J Biol Chem. 2008; 283: 17362-17369. doi: 10.1074/jbc.M709887200 PMID: 18430737
57. Bettini ML, Kersh GJ. MAP kinase phosphatase activity sets the threshold for thymocyte positive selection. Proc Natl Acad Sci U S A. 2007; 104: 16257-16262. PMID: 17901205
58. Moon SJ, Lim MA, Park JS, Byun JK, Kim SM, Park MK, et al. Dual-specificity phosphatase 5 attenuates autoimmune arthritis in mice via reciprocal regulation of the Th17/Treg cell balance and inhibition of osteoclastogenesis. Arthritis Rheumatol. 2014; 66: 3083-3095. doi: 10.1002/art.38787 PMID: 25047518
59. Jeffrey KL, Brummer T, Rolph MS, Liu SM, Callejas NA, Grumont RJ, et al. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nat Immunol. 2006; 7: 274-283. PMID: 16474395
60. Zhang Y, Blattman JN, Kennedy NJ, Duong J, Nguyen T, Wang Y, et al. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature. 2004; 430: 793-797. PMID: 15306813